Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Chinese

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2025, Vol. 30 ›› Issue (9): 1272-1280.doi: 10.12092/j.issn.1009-2501.2025.09.014

Previous Articles     Next Articles

Research progress on the mechanism of quercetin in preventing and treating acute lung injury

LIN Yiyan1,2, WU Yueying2, YAN Rui1, WU Dong1   

  1. 1 Department of Respiratory and Critical Care Medicine, Affiliated Hospital of Guangdong Medical University, Zhanjiang 524000, Guangdong, China; 2 First Clinical Medical College of Guangdong Medical University, Zhanjiang 524000, Guangdong, China
  • Received:2024-11-11 Revised:2025-01-07 Online:2025-09-26 Published:2025-09-09

Abstract:

Acute lung injury is an acute and critical respiratory disease with complex pathogenesis, which has a high incidence rate and high mortality. At present, acute lung injury is mainly treated by mechanical ventilation, glucocorticoid anti-inflammatory and extracorporeal membrane oxygenation. Traditional Chinese medicine also shows great potential in improving the clinical manifestations and prognosis of patients. Quercetin is a flavonol compound, which can prevent and treat acute lung injury by anti-inflammatory, anti-oxidative stress, regulating programmed cell death, antibacterial and antiviral. This article summarizes the mechanism of action and research progress of quercetin in the treatment of acute lung injury, aiming to provide reference for subsequent research and clinical applications.

Key words: quercetin, acute lung injury, anti-inflammatory, anti-oxidant stress, ferroptosis

CLC Number: